Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sapropterin Dihydrochloride in Symptomatic Peripheral Arterial Disease
NCT00403494Phase 2Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Dec 2006
- Primary completion
- Nov 2008
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of sapropterin in Peripheral Arterial Disease (PAD), intermittent claudication (IC), sponsored by BioMarin Pharmaceutical. Started Dec 2006; status: completed.
02
Drugs
sapropterin
03
Conditions
Peripheral Arterial Disease (PAD)intermittent claudication (IC)
Beyond the preview
Go deeper on NCT00403494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403494.